| 2024/09/26 22:00:02 | |
|---|---|
| Price | |
| 361.35 USD | |
| Difference | 0.51% (1.85) |
General attributes
| ISIN | US8636671013 |
| Symbol | SYK |
| Exchange | NYSE |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 123,212 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 357.75 USD (100) |
| Ask (Ask size) | 365.87 USD (100) |
| Open | 362.00 USD |
| High | 363.50 USD |
| Low | 358.3101 USD |
| Close (prev. day) | 359.50 USD |
| VWAP | 360.856618 USD |
| Volume (pcs) | 1,431,782 |
| Trading volume | 516,675,987.44 |
| Number of trades | 25,994 |
| Last size | - |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: STRYKER CORP. |  |
Add Benchmark:
Recent research
| Date | Headline | Download | |
| 2024/09/11 |
|
Global Equity Ratings |
|
| 2024/09/05 |
|
Global Equity Ratings |
|
| 2024/08/12 |
|
Global Equity Ratings |
|
| 2024/07/24 |
|
Global Equity Ratings |
|
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/09/26 22:00:02 | |
|---|---|
| Price | |
| 361.35 USD | |
| Difference | 0.51% (1.85) |
General attributes
| ISIN | US8636671013 |
| Symbol | SYK |
| Exchange | NYSE |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 123,212 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 357.75 USD (100) |
| Ask (Ask size) | 365.87 USD (100) |
| Open | 362.00 USD |
| High | 363.50 USD |
| Low | 358.3101 USD |
| Close (prev. day) | 359.50 USD |
| VWAP | 360.856618 USD |
| Volume (pcs) | 1,431,782 |
| Trading volume | 516,675,987.44 |
| Number of trades | 25,994 |
| Last size | - |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +3.13% | +32.10% | +30.62% |
| Perf (abs.) | +10.97 | +87.80 | +84.71 |
| Beta | 0.60 | 0.61 | 0.92 |
| Volatility | 19.03 | 20.29 | 25.69 |
Add Benchmark:
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 362.64 USD (1,207,013) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 357.91 USD (1,096,954) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 342.23 USD (1,250,051) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 324.75 USD (1,358,213) |
| YTD High | date | 374.63 USD (2024/09/16) |
| YTD Low | date | 292.43 USD (2024/01/03) |
| 52 Weeks High | date | 374.63 USD (2024/09/16) |
| 52 Weeks Low | date | 249.98 USD (2023/10/13) |
All listings for STRYKER CORP.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Vienna Stock Exchange | 2024/09/26 | 17:32 | 321.20 EUR | 0.00 | 5 |
| Tradegate | 2024/09/26 | 22:26 | 323.30 EUR | 0.16 | 39 |
| Stuttgart | 2024/09/26 | 21:31 | 323.10 EUR | 0.02 | 8 |
| NYSE | 2024/09/26 | 22:00 | 361.35 USD | 516.68 | 25,994 |
| Munich | 2024/09/26 | 08:00 | 322.80 EUR | 0.00 | 2 |
| London Stock Exchange | 2024/09/26 | 16:01 | 359.9887 USD | 0.49 | 5 |
| Hanover | 2024/09/26 | 17:25 | 320.80 EUR | 0.00 | 4 |
| Frankfurt | 2024/09/26 | 18:22 | 322.40 EUR | 0.01 | 3 |
| Euronext Milan MTF Trading After Hours | 2024/06/19 | 19:16 | 338.20 EUR | 0.00 | 1 |
| Euronext Milan MTF Global Equity Market | 2024/09/26 | 17:44 | 321.20 EUR | 0.00 | 1 |
| Duesseldorf | 2024/09/26 | 08:10 | 322.70 EUR | 0.00 | 3 |
| Berlin | 2024/09/26 | 08:01 | 322.70 EUR | 0.00 | 3 |
Company Logo
Contact Details
| STRYKER CORP. |
| - - |
| 1941 Stryker Way - 49002 Portage |
| Telefon: +1-269-385-2600 |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: STRYKER CORP. | |
Company Profile
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI. |
Members of Management Board
| Giovanni Caforio | Member of Board of Directors |
| Allan Golston | Member of Board of Directors |
| Andrew Silvernail | Member of Board of Directors |
| Howard Cox | Member of Board of Directors |
| John Brown | Member of Board of Directors |
| Lisa Tatum | Member of Board of Directors |
| Mary Brainerd | Member of Board of Directors |
| Rachel Ruggeri | Member of Board of Directors |
| Rajeev Suri | Member of Board of Directors |
| Ronda Stryker | Member of Board of Directors |
| Sherilyn McCoy | Member of Board of Directors |
| Kevin A. Lobo | Chairman of Managing Board |
| Glenn S. Boehnlein | Member of Executive Committee |
| M. Kathryn Fink | Member of Executive Committee |
| Robert S. Fletcher | Member of Executive Committee |
| Yin C. Becker | Member of Executive Committee |